Cerebrospinal fluid apoe glycosylation associates with biomarkers of Alzheimer’s Disease pathology
Dobrin Nedelkov, Zoe Tsokolas, Isabel Sible, Wendy J Mack, S Duke Han, John CS Rodman, Hussein N Yassine · 2025
Read Cerebrospinal fluid apoe glycosylation associates with biomarkers of Alzheimer’s Disease pathology by Dobrin Nedelkov, Zoe Tsokolas, Isabel Sible, Wendy J Mack, S Duke Han, John CS Rodman, Hussein N Yassine (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714275.txt.
Description
Dobrin Nedelkov and six co-authors study how a sugar coating on a key blood protein in spinal fluid links to signs of Alzheimer's disease, in a 2025 conference paper. The protein is apolipoprotein E, and one form of its gene is the strongest known gene risk for the late form of the disease. The team asked whether the coating level tracks with tau and amyloid in the fluid.
They tested blood and spinal fluid from 188 older adults in a long running imaging study. The risk form of the protein carried the least coating, and lower coating in spinal fluid went with worse tau levels over ten years. Higher coating went with more of a healthy amyloid form in the fluid. The authors say the coating may help shape how the disease unfolds.
Catalog record
| CREATOR | Dobrin Nedelkov, Zoe Tsokolas, Isabel Sible, Wendy J Mack, S Duke Han, John CS Rodman, Hussein N Yassine |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 3 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |